Ligand profile
CHEMBL117105
Bioactivity hit from ChEMBL on a similar protein.
Bound to: KP13_01960 — Dihydrofolate reductase
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL117105- UniProt (similar protein)
P0ABQ4- pchembl
- 8.870 (~1.3 nM)
- Target protein
- KP13_01960
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 102.8
- −1 ≤ LogP ≤ 5 1.07
- MW ≤ 500 Da 265.7
- LogP ≤ 5 1.07
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 102.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cc1cc(CC2CN=C(N)N=C2N)cc(Cl)c1NCc1cc(CC2CN=C(N)N=C2N)cc(Cl)c1N
InChI=1S/C12H16ClN5/c1-6-2-7(4-9(13)10(6)14)3-8-5-17-12(16)18-11(8)15/h2,4,8H,3,5,14H2,1H3,(H4,15,16,17,18)InChI=1S/C12H16ClN5/c1-6-2-7(4-9(13)10(6)14)3-8-5-17-12(16)18-11(8)15/h2,4,8H,3,5,14H2,1H3,(H4,15,16,17,18)
NOMYWMRDLICAMC-UHFFFAOYSA-NNOMYWMRDLICAMC-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- ChEMBL
- Binding sites
- PF00186
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL117105 →
- UniProt UniProt P0ABQ4 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL117105”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_01960.
PDB 34
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 99
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).